- Home
- MRK
as 08-07-2025 4:00pm EST
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
| Founded: | 2000 | Country: | United States |
| Employees: | N/A | City: | RAHWAY |
| Market Cap: | 198.5B | IPO Year: | N/A |
| Target Price: | $111.14 | AVG Volume (30 days): | 12.4M |
| Analyst Decision: | Buy | Number of Analysts: | 15 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 6.49 | EPS Growth: | 20.41 |
| 52 Week Low/High: | $73.31 - $120.30 | Next Earning Date: | 07-29-2025 |
| Revenue: | $63,616,000,000 | Revenue Growth: | 1.82% |
| Revenue Growth (this year): | 2.27% | Revenue Growth (next year): | 5.68% |
Latest Merck & Company Inc. (new) News
MRK Breaking Stock News: Dive into MRK Ticker-Specific Updates for Smart Investing
GlobeNewswire
a day ago
United States Vaccines Market Insights and Forecasts 2024 & 2025-2033 | Rising Infectious Disease Burden, Robust Funding and Regulatory Support Accelerate Innovation
GlobeNewswire
a day ago
United States Pharmaceutical Market Forecast and Company Analysis Report 2025-2033 Featuring F. Hoffmann-La Roche, Novartis, Abbvie, Johnson & Johnson, Merck, Pfizer, BMS, Sanofi, GSK, Takeda
The Wall Street Journal
a day ago
Health Care Roundup: Market Talk
The Wall Street Journal
a day ago
Germany’s Merck Raises Earnings Growth Guidance, But Turns Cautious on Sales
MT Newswires
2 days ago
Halozyme Therapeutics Guidance Upgrade Driven by Robust Royalty Revenue, Morgan Stanley Says
Insider Monkey
2 days ago
Merck & Co. (MRK) Slid on Weaker Market Sentiment and Concerns About Drug Pipeline
Motley Fool
2 days ago
Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?
Pharma Voice
2 days ago
PBM reform was dropped from Trump’s spending bill. It could have saved billions.
Compare MRK vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MRK Merck & Company Inc. (new) - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.